Insulin Delivery Devices Market Detailed Study Analysis with Forecast by 2025

The global insulin delivery devices market features a largely fragmented vendor landscape, according to a recent report by Transparency Market Research. The intense level of competition in the market owing to the presence of several international and local players has compelled vendors to introduce products with competitive pricing and differentiating features. The focus on strategic alliances, collaborations with the constantly rising numbers of diabetes clinics, and aggressive marketing practices has increased in the recent years.

Get Report Sample @

The report states that the market will exhibit a promising 8.6% CAGR from 2017 to 2025, rising to a valuation of US$20.9 bn by the end of 2025 from US$10.2 bn in 2016.

Insulin Pens to Remain Most In-demand Product Variety

Geographically, the market in North America held the top spot in the global insulin delivery devices market, acquiring a nearly 37% of the overall demand in 2016. The high prevalence of the condition in the U.S. and the high rate of adoption of advanced mechanisms are expected to help the region maintain its spot over the forecast period as well. In terms of the variety of insulin delivery devices available in the market, the segment of insulin pen accounted for the dominant 42% share of overall global demand in the said year.

Rising Global Burden of Diabetes to have High Impact on Market Growth

The rapidly spreading epidemic of diabetes across the globe has kept the interest level in diabetes-related R&D immensely high in the recent years. Despite the condition affecting millions of people worldwide, scientists and researchers have not been able to find a cure for the disease and controlling it by the effective and timely administration of insulin remains an indispensable measure for patients with type-1 diabetes to lead a normal life.

Thus in the absence of a complete and effective cure for diabetes, the emphasis largely lies on making insulin therapy better and more successful As a result, the continuous quest for new and pioneering therapies and insulin delivery measures continues and is reflecting positively on the overall global market for insulin delivery devices. The market also benefits massively from the constant rise in the number of vendors, R&D activities, technological advancements in products, and easy availability of advanced products across the globe. Moreover, favorable reimbursement scenario in developed nations and a constant rise in awareness programs across developing economies are also working in favor of the market.

Positive Development of Safety Needles to have High Impact on Growth Prospects

Although the market displays mostly positive growth prospects, a handful of factors could hinder its expansion as expected. One of the key challenges facing the market is the lack of encouraging medical reimbursement policies in several emerging economies. With a rapidly rising pool of diabetics in emerging countries across regions such as Asia Pacific and Latin America, the lack of encouraging reimbursement scenario could act as a big blow for international firms wanting to exploit the massive growth opportunities.

Additionally, needle anxiety among patients and the positive pace of development of oral insulin, which could act as an effective alternative to IV and subcutaneous insulin could hamper the market to a certain extent. Nevertheless, promising developments in the area of safety needles and a rise in diabetes-related expenditure and R&D activities in a number of countries could open up favorable growth avenues for companies operating in the market for insulin delivery devices.

View Report @

Insulin Delivery Devices Market: Intense Research on Diabetes Management Supports Growth

The demand in the global insulin delivery devices market is projected to increment at a robust CAGR of 8.6% during the forecast period of 2017 to 2025, gaining traction from a number of factors, but none bigger than the prevalence of diabetes, which is a highly common chronic disease that affected about 8.5 of the global population in 2014, according to the figures provided by the World Health Organization (WHO). Advancements in insulin delivery devices with improving technology, government initiatives to impart awareness, and appreciative reimbursement environment in a number of developed countries are some of the other factors favoring the global insulin delivery devices market. On the other hand, the lack of awareness regarding the availability of alternative insulin delivery methods such as oral and poor reimbursement policies in a number of developing countries are hindering the market from achieving its true potential.

Get Report Sample @

As per the estimations of this report, the global insulin delivery devices market will be worth US$20,996.2 mn by the end of 2025, notably up from its evaluated valuation of US$10,160 mn in 2016. While insulin pens is the most in-demand product segment, North America is most profitable regional market. Escalated research and development activities regarding diabetes-case is expected to open new revenue avenues for the vendors operating in the global insulin delivery devices market.

Insulin Pens Make Highly Profitable Product Segment

The global insulin delivery devices market, on the basis of product, has been segmented into insulin pens, insulin syringes, insulin pumps, needle-free injection jet, and insulin patches. Among these, insulin pens segment accounted for 42% of the total demand in 2016, and is projected to remain the most profitable product segment throughout the forecast period. This sustained demand for insulin pens is owing to its high adoption in the vastly populated region of Asia Pacific, along with the developed region of Europe. In these two regions, nearly 90% of the diabetic patients use insulin pens, a device that has not penetrated as much into the developed country of the U.S., wherein only 25% of the population use the product. That being said, the popularity of insulin pens is expected to increment steadily in the U.S. in the near future as its advantages such as flexibility and moderate pain.

View Report @

Easy Self-Administration Methods Boost Insulin Delivery Devices’ Demand

San Francisco, California, February 28, 2018: A recent report by TMR Research, titled, “Insulin Delivery Devices Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025”, offers a comprehensive analysis of this market with data extracted from extensive primary and secondary research.

Diabetes, also known as a silent killer disease, is a highly widespread disease, occurring in almost every region of the world. This is a primary driver of the global insulin delivery devices market, wherein provision of insulin is highly needed for those suffering from this disease. Highly fast and contrasting sedentary lifestyles, are emerging as important health concerns, consequently presenting increasing the chances of diabetes occurrence, thus boosting the market. A surge in sugar levels in the body might increase the chances of decreased insulin production, thereafter possible causing diabetes. This increase in sugar levels is a chief cause for rise in the requirement of insulin for processing the sugar, thus boosting the global insulin delivery devices market’s growth. Cardiovascular disorders and blood pressure problems might aggravate occurrence of diabetes, thus existing as primary propelling factors for boosting the insulin delivery devices market.

Get Sample Copy of this Report @

Extensive regulatory support provided for employing the use of insulin delivery devices is also likely to pose as a chief supporting aspect for improvement of the global insulin delivery devices market in future. From the perspective of hospitalization and healthcare, the market has strengthened due to better provision of reimbursement facilities. This is further expected to showcase improvement in sales of the insulin delivery devices market, thus pushing its growth towards a positive direction. Home-based medical care is another factor that is likely to boost the sales of insulin delivery devices, thus proving to be beneficial to the market. Self-administration of insulin is a favorable way of providing the hormone, in the context of long-term diabetes management. This is possible with minimum hassles by using the modern insulin delivery devices, and hence foster better growth in the global insulin delivery devices market.

From the perspective of insulin delivery devices available in the market, the insulin pen segment registered a leading share of 42% in 2016, as a result of easier handling and availability all across the world. Geography-wise, the global insulin delivery devices market is spread across North America, Asia Pacific, Middle East and Africa, Latin America, and Europe. From these, North America acquired a share of 37% in 2016, greater than any other region, consequently holding the leading segment spot. The widespread occurrence of diabetes in leading countries from North America such as the U.S. and Canada, as well as the high rate adoption of advanced insulin delivery mechanisms also are prime reasons for this region to garner a handsome market share.

The global insulin deliver devices market mainly showcases a highly fragmented vendor landscape. An intense competitive scenario exists within the assortment of players operating in this market, owing to the presence of several international and regional players. Subsequently, most market players are releasing products characterized by neck-to-neck pricing and feature differentiation, thus giving rise to a tough competitive outlook. Mergers, collaborations, and other similar activities are key strategies being employed by most players in the global insulin deliver devices market. Few companies are adopting strategies such as partnerships with diabetes specialty clinics, and other healthcare centers. Effective utilization of these strategies have caused many businesses to expand their product portfolio, thus securely establishing their position in the market. Aggressive marketing practices are being implemented by several players in the market in order to attract maximum revenue in the upcoming years. Eli Lilly and Company, Tandem Diabetes Care Inc., Becton, Dickinson, and Company, Medtronic plc, and Abbott, are some of the chief players operating in the insulin delivery market.